| Size & multiples | |||
| Market Cap | $7.72B | Enterprise Value | — |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 26.80× | P/FCF | 187.64× |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | — | EV/FCF | — |
| FCF Yield | 0.53% | Buyback Yield | — |
| Owner Earnings (TTM) | $22.3M | Owner Earnings Yield | 0.29% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.58 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 6.88% |
| After-tax Cost of Debt | — | Synthetic credit rating | B+ |
| Cost of Debt · embedded (pre-tax) | — | Cost of Debt · marginal (synthetic) | 6.75% |
| WACC | — | ROIC | — |
| EVA Spread (ROIC−WACC) | — | EVA | — |
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM -$0.80 · revenue TTM $288.1M · FCF TTM $41.1M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | -0.5% | -7.8% | -34.7%–1.4% | 67 ↑strong |
| Net Margin | -43.5% | -21.2% | -325.3%–7.2% | 43 ↓weak |
| Operating Margin | -32.5% | -34.5% | -552.0%–8.0% | 50 ↑strong |
| ROE | -111.1% | -36.8% | -92.5%–4.5% | 20 ↓weak |
